|
WO2020044298A1
|
|
A novel use of the anti-müllerian hormone
|
|
KR20150139919A
|
|
Progesteron receptor modulators for use in the therapy of uterine fibroids
|
|
EP2835136A1
|
|
Somatostatin Receptor Modulator for the treatment of infertility
|
|
EP2664325A1
|
|
Methods for preventing or treating androgen mediated diseases
|
|
EP2647379A1
|
|
Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
|
|
EP2647378A1
|
|
Steroid sulfatase inhibitor regimen for the treatment of endometriosis
|
|
EP2641602A1
|
|
Method for treating gynecological diseases
|
|
EP2545922A1
|
|
Treatment of excessive menstrual bleeding associated with uterine fibroids
|
|
WO2011151782A1
|
|
A role for somatostatin to modulate initiation of follicular growth in the human ovary
|
|
EP2471537A1
|
|
Treatment of pain associated with dislocation of basal endometrium
|
|
KR20100068287A
|
|
Treatment of oestrogen dependant conditions in pre-menopausal women
|
|
EP2149371A1
|
|
Use of steroid sulfatase inhibitors for the treatment of preterm labor
|
|
WO2008129396A2
|
|
Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding
|
|
US2006069031A1
|
|
Use of GnRH agonists to support the luteal phase during infertility treatment
|
